Repertoire
Roche’s Genentech builds autoimmune Repertoire with deal worth up to $765M
Repertoire, genentech, Autoimmune Diseases, Immune Medicines, Partnership
BMS Collaborates to Revolutionize Immunotherapy: The Repertoire Vaccine Partnership
BMS, Bristol-Myers Squibb, Repertoire, immunotherapy, vaccine, immune system reset, partnership, cancer treatment, personalized medicine.